126 related articles for article (PubMed ID: 3887313)
1. Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus.
Lilien LD; Srinivasan G; Yeh TF; Pildes RS
Pediatr Pharmacol (New York); 1985; 5(1):73-7. PubMed ID: 3887313
[TBL] [Abstract][Full Text] [Related]
2. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
[TBL] [Abstract][Full Text] [Related]
3. Is oral indomethacin effective in treatment of preterm infants with patent ductus arteriosus?
Satar M; Yapicioğlu H; Narli N; Ozbarlas N; Küçükosmanoğlu O; Tutak E
Turk J Pediatr; 2004; 46(2):137-41. PubMed ID: 15214742
[TBL] [Abstract][Full Text] [Related]
4. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
5. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
[TBL] [Abstract][Full Text] [Related]
6. A double blind study of the effects of oral indomethacin in preterm infants with patent ductus arteriosus who failed medical management.
Neu J; Ariagno RL; Johnson JD; Pitlick PT; Cohen RS; Beets CL; Sunshine P
Pediatr Pharmacol (New York); 1981; 1(3):245-9. PubMed ID: 7346744
[TBL] [Abstract][Full Text] [Related]
7. Indomethacin therapy in premature infants of advanced postnatal age.
Achanti B; Pyati S; Yeh TF
J Perinatol; 1987; 7(3):235-7. PubMed ID: 3504463
[TBL] [Abstract][Full Text] [Related]
8. Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels.
O'Donovan DJ; Fernandes CJ; Nguyen NY; Adams K; Adams JM
Am J Perinatol; 2004 May; 21(4):191-7. PubMed ID: 15168317
[TBL] [Abstract][Full Text] [Related]
9. When to treat the patent ductus arteriosus with indomethacin in very-low-birth-weight infants.
Mahony L; Heymann MA; Carnero V; Brett C; Clyman RI
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():491-4. PubMed ID: 6221636
[No Abstract] [Full Text] [Related]
10. [An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants].
Lozano González CH; Holden AM; Hurtado del Río D; Segura MA
Bol Med Hosp Infant Mex; 1982 Aug; 39(8):570-5. PubMed ID: 7182006
[No Abstract] [Full Text] [Related]
11. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus.
Betkerur MV; Yeh TF; Miller K; Glasser RJ; Pildes RS
Pediatrics; 1981 Jul; 68(1):99-102. PubMed ID: 6909683
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus.
Brash AR; Hickey DE; Graham TP; Stahlman MT; Oates JA; Cotton RB
N Engl J Med; 1981 Jul; 305(2):67-72. PubMed ID: 7242577
[TBL] [Abstract][Full Text] [Related]
13. Intrauterine inflammation as a risk factor for persistent ductus arteriosus patency after cyclooxygenase inhibition in extremely low birth weight infants.
Kim ES; Kim EK; Choi CW; Kim HS; Kim BI; Choi JH; Park JS; Moon KC
J Pediatr; 2010 Nov; 157(5):745-50.e1. PubMed ID: 20598319
[TBL] [Abstract][Full Text] [Related]
14. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus.
Leonhardt A; Strehl R; Barth H; Seyberth HW
Acta Paediatr; 2004 Feb; 93(2):233-40. PubMed ID: 15046280
[TBL] [Abstract][Full Text] [Related]
15. Surgical closure of patent ductus arteriosus in 268 preterm infants.
Wagner HR; Ellison RC; Zierler S; Lang P; Purohit DM; Behrendt D; Waldhausen JA
J Thorac Cardiovasc Surg; 1984 Jun; 87(6):870-5. PubMed ID: 6374300
[TBL] [Abstract][Full Text] [Related]
16. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
[TBL] [Abstract][Full Text] [Related]
17. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.
O'Donovan DJ; Baetiong A; Adams K; Chen A; Smith EO; Adams JM; Weisman LE
J Perinatol; 2003 Jun; 23(4):286-90. PubMed ID: 12774134
[TBL] [Abstract][Full Text] [Related]
18. Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus.
Achanti B; Yeh TF; Pildes RS
Clin Invest Med; 1986 Nov; 9(4):250-3. PubMed ID: 3802612
[TBL] [Abstract][Full Text] [Related]
19. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
Cherif A; Jabnoun S; Khrouf N
Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
[TBL] [Abstract][Full Text] [Related]
20. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
Chotigeat U; Jirapapa K; Layangkool T
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
